Abstract: Heart valve disease is a serious and growing public health problem for which prosthetic replacement is most commonly indicated. Current prosthetic devices are inadequate for younger adults and growing children. Tissue engineered living aortic valve conduits have potential for remodeling, regeneration, and growth, but fabricating natural anatomical complexity with cellular heterogeneity remain challenging. In the current study, we implement 3D bioprinting to fabricate living alginate/gelatin hydrogel valve conduits with anatomical architecture and direct incorporation of dual cell types in a regionally constrained manner. Encapsulated aortic root sinus smooth muscle cells (SMC) and aortic valve leaflet interstitial cells (VIC) were viable within alginate/gelatin hydrogel discs over 7 days in culture. Acellular 3D printed hydrogels exhibited reduced modulus, ultimate strength, and peak strain reducing slightly over 7-day culture, while the tensile biomechanics of cell-laden hydrogels were maintained. Aortic valve conduits were successfully bioprinted with direct encapsulation of SMC in the valve root and VIC in the leaflets. Both cell types were viable (81.4 6 3.4% for SMC and 83.2 6 4.0% for VIC) within 3D printed tissues. Encapsulated SMC expressed elevated alpha-smooth muscle actin, while VIC expressed elevated vimentin. These results demonstrate that anatomically complex, heterogeneously encapsulated aortic valve hydrogel conduits can be fabricated with 3D bioprinting. V C 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 00A:000-000, 2012.
INTRODUCTION
Heart valves ensure critical one-way blood flow through the cardiovascular system. The aortic valve is particularly important, as it directs blood through the aorta and coronary arteries. Efficiency of valve performance is controlled by its complex anatomical geometry and heterogeneous tissue biomechanics. 1 Congenital malformations and/or acquired valve diseases compromise valve shape and/or tissue mechanics, leading to the narrowing of valve orifice area (stenosis) or leaking (regurgitation). Aortic valve disease is a significant cause of morbidity and mortality. 2 While the aortic valve can sometimes be surgically repaired, prosthetic replacement is only option for the vast majority of patients. 3 Mechanical valves are durable but suffer risks of clot formation on their prosthetic surfaces, necessitating life-long anticoagulant drug therapy. Bioprosthetic valves, on the other hand, have minimal risk for bleeding events but are much less durable and unsuitable for pediatric applications. 3, 4 The pulmonary autograft, or Ross procedure, is an attractive option to provide a living valve in the aortic position, but recent studies suggest that the pulmonary conduit may pathologically dilate, particularly in growing children. 5 Tissue engineering is a promising alternative strategy with the potential to provide a living valve replacement capable of integration with host tissue and growth. 6 A common fabrication process is to mold a valve shape from a biodegradable scaffold material, seed it with cells, and culture it in vitro, often under dynamic stimulation, before implantation. [7] [8] [9] [10] [11] A wide range of synthetic polymers, such as polyglycolic acid and poly-4-hydroxybutyrate, and natural biomaterials such as fibrin and collagen have been employed to generate 3D heart valve scaffolds. 9, [12] [13] [14] Electrospinning has been utilized to create nanofibrous membranes that exhibit anisotropic biomechanical properties like that of the native valve leaflet. 15, 16 However, few attempts have been made to engineer heart valve conduits (root and integrated leaflets). Using molds necessitates a single material formulation (and the same cell type if included) for both valve root and leaflets and thus creates homogeneous material biomechanics. This approach risks creating root walls that are too compliant or cusps that are too stiff. Even complex mold shapes have significant challenges to replicate valve sinuses and coronary ostia, which are important for optimal hemodynamic performance. 17 Bioprinting approaches employing layer-by-layer additive fabrication technology have recently been employed to produce three-dimensional (3D) biological materials that exhibit high resolution geometric and/or mechanical complexity, including inkjet bioprinting, laser-assisted bioprinting, and 3D bioprinting. 18, 19 3D bioprinting implements rapid prototyping (RP) techniques, which follows computerassisted design (CAD) and/or computer-assisted manufacturing (CAM) blueprints to build a complex tissue construct. 20 Several studies have demonstrated the capacity of 3D bioprinting to fabricate 3D structures for various tissue regeneration applications or biomedical devices, including knee menisci, blood vessels, and liver. [21] [22] [23] Most hydrogel bioprinting studies to date have fabricated relatively simple slabs or self-supporting structures that are unsuitable for the geometric complexity of heart valves. 22, 24 Stereolithography (STL)-based printing can create intricate 3D shapes, but the fabrication process is cyotoxic. Conversely, two-photon laser based photocrosslinking can create directly encapsulated 3D tissues with high spatial resolution, but only a few millimeters in overall size, which is clinically inadequate. 25, 26 Recently, new biomaterials with capacity for photopolymerization or thermosensitivity have been adapted for 3D bioprinting, including A-B-A triblock copolymer hydrogel composed of poly(N-(2-hydroxypropyl)methacrylamide lactate) A-blocks, partly derivatized with methacrylate groups, and hydrophilic poly(ethylene glycol) Bblocks, 27 and hydroxyethyl-methacrylate-derivatized dextran (dex-HEMA). 24 Hybrid tissue fabrication strategies are also possible through alternating deposition of thermoplastic materials and cell-laden hydrogels.
28 3D bioprinting may therefore be a promising technology for rapid fabrication of intrinsically complex, cell encapsulated aortic valve conduits.
In this study, we test the ability for 3D bioprinting to utilize alginate/gelatin hydrogel formulations to fabricate living heterogeneous aortic valve conduits. We quantify 3D printing accuracy, printed and evolved tissue biomechanics, and cell differentiation.
MATERIALS AND METHODS

Cell isolation
Porcine aortic valves were obtained at a slaughterhouse (Shirk Meats, Himrod, NY). Porcine aortic valve interstitial cells (VIC) were isolated via collagenase digestion of the leaflets after endothelial cells were removed as previously described. 29 Human aortic root smooth muscle cells (SMC)
were isolated from the aortic root of a 12-year old young patient while undergoing cardiac transplant for a non-valve problem. The aortic root was inspected to be grossly normal. 6 cells/mL. Each cell laden alginate/ gelatin gel was loaded into syringe and directly extruded into disc molds (Ø8 mm Â 1 mm). The resultant alginate/ gelatin gel discs were then ionically crosslinked by calcium chloride (CaCl 2 , 300 mM, Sigma) for 5 min. Gelatin was gradually released from ionically crosslinked hydrogel discs detected by bicinchoninic acid Protein Assays (Pierce) (Supporting Information Fig. S1 ).
Bioprinting of 3D constructs
Three different 3D geometries were designed and printed. First, square grid patterns were first designed to evaluate accuracy of 3D printing with alginate/gelatin. A grid pattern was designed and converted into vector file format, as shown in Figure 5 (A). The distance between each printed line is 2 mm. We measured the channel dimensions in both X and Y directions and the printing accuracy was assessed by comparing the measured channel area to the design value (4 mm 2 ) using the following equation:
where A i is measured channel area, A is design area (4 mm 2 ) and n represents total number of channel in a printed construct. Three printed constructs were used for the printing accuracy test. Next, a dumbbell-shaped model was designed and fabricated to determine mechanical properties of cell-free 3D printed alginate/gelatin hydrogels. We designed an 80% scaled version of ASTM D638-10 type V, with thickness of 3.20 mm; width of 2.54 mm, gage length of 6.10 mm, and 20.32 mm distance between grips. This was converted into STL format and imported into the 3D bioprinter software.
For the 3D aortic valve model, freshly harvested porcine aortic valves (Shirk Meats, Himrod, NY) were rinsed with sterile phosphate buffered saline (PBS), preserved in formalin, and then scanned using micro-CT (GE eXplore CT120; GE Health Care, Milwaukee, WI) at 100 lm resolution, 80 keV, 30 mA, 800 angles, 30 ms exposure time, 30 gain, and 20 offset. 30 The root and leaflet regions in the scans were identified with intensity thresholds and rendered separately into 3D geometries into STL format [ Fig. 6 (A) green for root and red for leaflet]. 31 The Fab@Home TM open-source, open-architecture RP platform (www.fab@home.org) was used for printing the alginate/gelatin gels. The vector file (for 3D grid patterned bioprinting) and STL file (for bioprinting of dumbbell-shaped tensile test samples and living aortic valve conduit) were imported into the printer. The software converted the imported STL file into print paths by slicing them into layers and generating contour and fill-paths for each layer based on specific print parameters. 31 The standard print head was modified to incorporate three linear actuator-driven deposition tools with interchangeable syringe tips with inner diameter of 800 lm (EFD Inc, East Providence, RI) that can be positioned on the XY plane with 25 lm precision. Alginate/gelatin hydrogel formulations were then loaded aseptically into the deposition syringes. Gels were extruded along the X-Y target paths for each layer, and after each layer completed the print stage it was translated Z (for 3D aortic valve model), thus sequentially building the construct. The standard printing parameters used in our experiments were 0.8 mm path width, 0.7 mm path height, and 5 mm/s path speed. SMC or VIC were mixed into the alginate/gelatin gel at a density of 1 Â 10 7 cells/mL. Only one cell type (VIC) was encapsulated within the printed 3D square grid patterns or dumbbellshaped tensile test samples. Both cell types (SMC for the root and VIC for the leaflets) were encapsulated in the bioprinted aortic valve conduits. Each cell type was mixed in its own hydrogel and contained in separate syringes. The printer software controlled extrusion from each syringe so that the root section of each layer was fabricated first, followed by the leaflet component. After each print was completed, the final structures were then ionically crosslinked in CaCl 2 (300 mM) for 10 min.
Tensile biomechanics tests
Uniaxial tensile properties of printed and ionically crosslinked cell-free and cell-encapsulated dumbbell-shaped hydrogels were tested after 0, 1, and 7 days culture using an ELF 3200 (EnduraTec) mechanical test-frame. A 1 kg load cell (Sensotec) with 2 g resolution was attached to the bottom plate and a displacement sensor to the top plate. The cross-head speed was 0.075 mm/s and the gauge length was about 20 mm. Load data were acquired at a frequency of 5 Hz, and displacement and load data were converted to strain and stress, respectively, by normalizing to sample thickness and area.
Cell viability and spreading in gels
The viability of encapsulated cells was determined using live/dead cell viability assays (Invitrogen) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay according to manufacturer's instructions. For live/ dead assay, fluorescence images were obtained immediately using a confocal microscopy (CLSM, LSM 710, Carl Zeiss). Cell viability was measured via counting live (green) and dead (red) cells using ImageJ. The MTT assay was conducted on VIC and SMC encapsulated in alginate/gelatin hydrogel discs at both low (2 Â 10 6 cells/mL) or high cell density (1 Â 10 7 cells/mL) (Supporting Information Materials).
SMC and VIC were incubated for 30 min with CellTracker TM Green CMFDA and CellTracker TM Red CMPTX (Invitrogen), respectively. The 3D bioprinted constructs with cell tracker labeled cells were imaged after crosslinking. Cell spreading and circularity was quantified via ImageJ (Analyze Particles feature) by measuring the average surface area per cell and cell shape. Circularity ranges from 0 to 1, with 1 indicating a perfect circle and 0 a straight line.
Cell phenotype analysis Cultured cell laden hydrogels were fixed by 4% paraformaldehyde in PBS for 4 h at 4 C, permeabilized in 0.2% Trion X-100 for 10 min at room temperature, and blocked with 1% bovine serum albumin (BSA) overnight at 4 C. To visualize actin cytoskeletal filaments, the hydrogels were stained by Alexa Fluor 488 conjugated phalloidin (1:40, Invitrogen). Hydrogels were also treated with primary antibodies to alpha smooth muscle actin (aSMA) (1:100, rabbit monoclonal anti-aSMA, Spring Biosciences), vimentin (1:100, mouse monoclonal anti-vimentin, Invitrogen), or type I collagen (Col1A2, 1:100, Santa Cruz Biotechnology), each overnight at 4 C. Vimentin is expressed by fibroblasts and other mesenchymal cells, while aSMA is a contractile filament primarily in SMC. 32, 33 Secondary fluorescent antibodies and nuclear counterstaining (via Draq 5, 1: 1000, Biostatus) were performed for 30 min at room temperature. Samples were imaged with Zeiss 710 CLSM as before. Protein expression was quantified as area of staining intensity above a threshold using ImageJ as previously described.
34-36
Statistical analysis All quantitative data are expressed as the mean 6 standard (SD). Six images were analyzed for each hydrogel sample (hydrogel disc or bioprinted hydrogel valve conduit). Four to six printed cell-free hydrogel samples and three cellloaded samples were used for tensile testing. Statistical analysis was performed using ANOVA with Scheff e post-hoc tests. A value of p < 0.05 was considered to be statistically significant and p < 0.01 remarkably significant.
RESULTS
Cell encapsulation within hydrogel discs VIC and SMC encapsulated within alginate/gelatin hydrogel discs were viable at both 1 and 7 days [ Fig. 1(A,B) ]. Cell viability for the encapsulated VIC was (91.2 6 5.7)% at day 1 [ Fig. 1(C) ]. Most VIC were not spread 1 day after printing, but maintained spherical morphology (circularity of 0.90 6 0.15). There was no change in VIC viability at day 7 [(86.0 6 4.6)%, p ¼ 0.22)], but cells were significantly more spread with decreased circularity (0.76 6 0.21, p < 0.05).
The projected cell area of VIC increased from 127.1 6 99.4 lm at day 1 to 201.4 6 178.1 lm at day 7 [ Fig. 1(D) ]. Similarly, high cell viability for SMC encapsulation was maintained in culture [(90.7 6 3.0)% for 1 day and (84.6 6 5.1)% for day 7, Fig. 2(A-C) ]. SMC projected cell area and spreading both significantly increased over the culture period (circularity of 0.91 6 0.06 for day 1 and 0.80 6 0.17 for day 7, p < 0.05.), but SMC were less spread than VIC overall. Cytoskeleton F-actin of encapsulated VIC and SMC was performed after 7 day culture [ Fig. 3(A,C) ]. The encapsulated VIC were more extensively spread after 7 day culture.
Imaging analysis as semi-quantitative measurement using ImageJ was conducted to generally compare the expression of aSMA and vimentin within the encapsulated VIC and SMC. As shown in Figure 3(B) , the encapsulated VIC express both aSMA and vimentin, but the expression of vimentin was significantly higher than aSMA expression, suggesting a more fibroblastic than myofibroblastic phenotype. The expression trends for SMC were reversed: aSMA was significantly higher than vimentin [ Fig. 3(D) ]. aSMA staining was more diffuse than organized fibrils, which was not surprising given their limited spreading after 7 days culture.
Hydrogel tensile biomechanics
Alginate/gelatin hydrogels exhibit mostly linear stressstrain behavior, with significant extensibility and mechanical strength [ Fig. 4(A) ]. The ultimate tensile strength in cellfree hydrogels decreased from 0.84 6 0.07 MPa to 0.64 6 0.12 MPa after 24 h, and further decreased to 0.40 6 0.04 MPa after 7 days immersion [p < 0.05, Fig. 4(C) ]. Similarly, the elastic modulus decreased from 1.44 6 0.30 MPa to 0.99 6 0.14 MPa after 24 h (p < 0.05), but this stiffness was maintained out to 7 days [0.96 6 0.08 MPa, Fig. 4(E) ].
The ultimate tensile strength and failure strain for hydrogels encapsulated with VIC were 0.35 6 0.06 MPa and 38.76 6 3.82% respectively, significantly decreased compared to cell-free hydrogels (p < 0.01). However, there was no significant difference in hydrogel modulus with and without cells at day 0. However, the tensile mechanics of cell-laden hydrogels did not change over culture, becoming statistically equivalent to cell-free samples after 7 day incubation [ Fig. 4(B-E) ]. This is partly explained by the secretion of extracellular matrix proteins by encapsulated cells, including type I collagen [ Fig. 4(F) ].
Bioprinting of 3D patterned constructs
A simple 3D structure with grid type pattern was first designed and printed, as shown in Figure 5 (A). The alginate/gelatin hydrogel with encapsulation of VIC maintained its geometry and mechanical integrity after extrusion and crosslinking [ Fig. 5(B) ]. The printing accuracy (percentage overlap of printed to designed area) was (84.3 6 10.9)%. Cells were evenly distributed throughout the printed tissue [ Fig. 5(C,D) ]. Cell viability after 7 days culture was determined via live/dead staining to be (84.6 6 3.1)% [ Fig.  5(E) ]. These results support the printability of alginate/gelatin hydrogel with good fidelity of defined geometries and high encapsulated cell viability.
Bioprinting of heterogeneous aortic valve conduits SMC and VIC were encapsulated within separate alginate/ gelatin hydrogel preparations. Figure 6 (A) shows the 3D model of porcine aortic valves reconstructed from micro-CT images. The leaflet and root regions were thresholded based on tissue density and reconstructed into two printable STL geometries (green for root and red for leaflet) and input into the Fab@Home TM system for bioprinting. A schematic diagram of the dual cell type bioprinting process is shown in Figure 6 (B,C) for the root and leaflet regions of the first layer. Using the dual-syringe Fab@Home bioprinter, the root (SMC laden hydrogel) was deposited first and subsequently, the leaflet region of the layer (VIC laden hydrogel) was extruded along its print paths. These steps were repeated for the subsequent layers to yield a 3D construct with the desired architecture and heterogeneous cell distributions. Valves were printed with high cell density (1 Â 10 7 cells/ mL) instead of low (2 Â 10 6 cells/mL), since higher cell density was proved to better maintain the overall cell viability (Supporting Information Fig. S2 ). Heterogeneous cell distribution in printed tissue layers was verified by fluorescent labeling [ Fig. 6(D) ]. The 3D printed aortic valve conduit, complete with SMC and VIC encapsulated in the root and leaflet tissue, respectively, exhibited geometry comparable to the original image derived valve [cf., Fig. 6(A) and (E)). Key anatomical features, including sinuses and coronary ostia, were recapitulated faithfully. After 7 days additional culture, SMC encapsulated within the root had viability of (81.4 6 3.4)%, while encapsulated VIC had viability of (83.2 6 4.0)%. Unlike within hydrogel discs, the cells were less spread (148.8 6 99.6 lm 2 for VIC and 130.9 6 108.7 lm 2 for SMC) in the printed constructs. Both VIC and SMC expressed aSMA and vimentin protein after 7 days culture. VIC showed significant higher vimentin expression than aSMA [ Fig. 7(B) ], whereas SMC expressed more aSMA [ Fig.  7(D) ]. These results confirm the feasibility of 3D bioprinting for heterogeneous cell encapsulated clinically sized tri-leaflet heart valves.
DISCUSSION
3D bioprinting has great potential to fabricate heterogeneous tissues with multiple cell types, biohybrid materials, and/or different mechanical properties, all of which are critical for the advancement of tissue engineering. 22, 37 For example, aortic heart valve function is heavily dependent on its geometry and material composition. Engineering living tri-leaflet valves with anatomical and/or mechanical heterogeneity has been challenging with current fabrication strategies. In this study, we fabricated living aortic valve conduits with anatomical resemblance to the native valve based on alginate/gelatin hydrogel system via 3D bioprinting. Aortic valve root cells (SMC) and leaflet cells (VIC) were encapsulated within alginate/gelatin hydrogel and bioprinted in a dual syringe system to mimic the structure of valve root and leaflet, respectively. Various bioprinting machines based on deposition technique have been used for formation of 3D constructs. Most studies focused on homogenous 3D bioprinting with single material and single cell type. 38, 39 We evaluated print accuracy in simple grid patterns as a means to rapidly optimize hydrogel formulation without having to print the whole valve. Both overall shape and internal pore structure were well preserved after bioprinting and further crosslinking. Both bioprinting parameters and hydrogel properties can affect the shape fidelity. Although we optimized the parameters for printing of alginate/gelatin hydrogel, the printing process paused at the end of each path for very short time, and the hydrogel was not totally sucked back, resulting in over extrusion at those locations. Therefore, the fidelity at central printed region was better than that at the edge region. More advanced determination of printing fidelity can be achieved using recently developed 3D shape comparison algorithms that compare directly against 3D image data. 31, 40 Alginate is a naturally occurring anionic polymer with many attractive features for biomedical applications, including low cost, excellent biocompatibility, low toxicity, and a variety of crosslinking and biomolecular tethering flexibililty. 41 Alginate-based hydrogels have been widely studied and used in wound healing, drug delivery, cell transplantation, and tissue engineering, 42, 43 but are also particularly attractive for bioprinting (both laser-assisted bioprinting and 3D bioprinting) due to its broad range of viscosities at room temperature. [44] [45] [46] This is important, as hydrogels have tight requirements with regard to viscosity and gelling speed for accurate printing. Forming a hydrogel with an alginate/gelatin combination required decreasing the temperature from 37 C to room temperature due to thermoreversibility of gelatin. The shear storage and loss moduli (G 0 and G 00 ) of alginate/gelatin significantly increased during gelation process indicating the increase of viscosity. 46 There are two roles that gelatin plays in these 3D printed tissues. First, gelatin alters the viscosity of the hybrid hydrogel to enable extrusion and printing. Approximately, 40% of the initial gelatin was present in the gel immediately after crosslinking, and about 20% of that was maintained in the gels over the 7-day period. This remnant gelatin may support cell adhesion and spreading. We employed different alginate/gelatin combinations during preliminary experiments. We found that with increasing proportion of alginate, the deposited hydrogel blend spread unacceptably, while elevated gelatin ratio resulted in increased viscosity that impaired the deposition process. With the optimal ratio of alginate to gelatin determined in this study, this hydrogel can be smoothly printed onto the platform and hold its shape until crosslinking via CaCl 2 .
The duration time and shear stress in the extrusion process and syringe tip diameter can influence the cell viability. 47 The moderate extrusion environment and ionic crosslinking process ensured high cell viability compared to small syringe tip and chemical crosslink. 24, 41 Both SMC and VIC showed high cell viability after encapsulated within the hydrogel discs (>90% for 1 day culture and >80% for 7 days). The slight decrease in cell number and overall viability over 7-day culture was likely due to some impairment of cell adhesion, which is commonly reported by other groups using alginate and other bioinert hydrogels such as poly(-ethylene glycol) and hyaluronic acid. [48] [49] [50] Therefore, these 3D hydrogel constructs can maintain high cell viability with clinically relevant thickness. The increase in cell spreading over culture was probably due to the temporal dissociation of alginate by gradual ion exchange process between Na þ and Ca 2þ ions, 43, 51 and increased availability of gelatin. Recent studies have highlighted that VIC are a heterogeneous population, exhibiting a continuum of fibroblast and myofibroblast phenotypes. 52 In our study, the encapsulated VIC expressed both vimentin and aSMA (though significantly more vimentin), characteristic of a myofibroblast phenotype. It has been reported that VIC can activate to a myofibroblast in response to mechanically stiff and/or remodeling or diseased microenvironments. 1, 53 Conversely, soft substrates promote fibroblast activity. 54 While the precise biomechanical thresholds for each have yet to be determined, the modulus of the alginate/gelatin hydrogels in future studies might need to be lowered for increased fibroblast phenotype.
The tensile stress and modulus of printed cell-free dumbbell-shaped hydrogel samples decreased with culture. This was likely caused by gradual dissociation via Na þ and Ca 2þ ion exchange and early release of gelatin (Supporting Information Fig. S1 ). The tensile stress and modulus of cellfree printed hydrogel samples were comparable to those for non-calcified human aortic heart valve cusps (around 1.74 6 0.29 MPa for tensile stress and 1.98 6 0.15 MPa for modulus at the level of stress 1.0 MPa in radial direction. However, hydrogels encapsulated with VIC had initially reduced tensile strength and failure strain compared to cellfree samples, probably due to the encapsulated cells that acted effectively like pores in the hydrogel samples. The encapsulated cells comprised a significant amount of the area of the hydrogels, but contributed minimally to the mechanics of the hydrogels when first deposited, as also reported previously with other hydrogels. 55 With increasing the culture time, the hydrogel alone decreased in stiffness and strength, while the cell-laden gels maintained them. The encapsulated VIC secreted their own extracellular matrix (ECM) including type I collagen, which likely compensated the effects of alginate dissociation and gelatin release. By day 7, the cell-laden constructs were $ 40% less stiff than the initial cell-free scaffold, which our data suggest supported a largely (but not complete) fibroblastic VIC phenotype. It will be critical in future studies to include biomechanical heterogeneity as well as cellular heterogeneity in 3D printed valves. 31 Changing the alginate to gelatin ratio can tune printed tissue mechanics, but the temperature around the hydrogel needs to be well controlled during printing in order to avoid premature gelation of gelatin. In addition, the chemical crosslinking performed in this study is a global process difficult to control and will limit the print time available. While smaller sized bioprinted valve conduits need less time for crosslinking, a similar decrease in spatial resolution will not reduce printing times. Photocrosslinking strategies may afford better control of tissue mechanics while not limiting the possible printing time. Inclusion of cell adhesion peptides and other biomacromolecules within the gel will likely improve cell viability, spreading, and proliferation. Further conduit culture within hemodynamic bioreactors can facilitate tissue remodeling and strengthening toward normal tissue architecture, likely an important step before future animal implantation studies.
CONCLUSIONS
We establish a method to fabricate mechanically robust living tri-leaflet heart valves using 3D printing and multiple valve cell populations. The encapsulated VIC and SMC had high viability, good spreading, and phenotype retention in culture. 3D bioprinted cell encapsulated valve conduits are thus a promising strategy for tissue engineered living valve replacements.
